469 related articles for article (PubMed ID: 17504874)
1. Three-dimensional radiobiologic dosimetry: application of radiobiologic modeling to patient-specific 3-dimensional imaging-based internal dosimetry.
Prideaux AR; Song H; Hobbs RF; He B; Frey EC; Ladenson PW; Wahl RL; Sgouros G
J Nucl Med; 2007 Jun; 48(6):1008-16. PubMed ID: 17504874
[TBL] [Abstract][Full Text] [Related]
2. Lung dosimetry for radioiodine treatment planning in the case of diffuse lung metastases.
Song H; He B; Prideaux A; Du Y; Frey E; Kasecamp W; Ladenson PW; Wahl RL; Sgouros G
J Nucl Med; 2006 Dec; 47(12):1985-94. PubMed ID: 17138741
[TBL] [Abstract][Full Text] [Related]
3. Accurate dosimetry in 131I radionuclide therapy using patient-specific, 3-dimensional methods for SPECT reconstruction and absorbed dose calculation.
Dewaraja YK; Wilderman SJ; Ljungberg M; Koral KF; Zasadny K; Kaminiski MS
J Nucl Med; 2005 May; 46(5):840-9. PubMed ID: 15872359
[TBL] [Abstract][Full Text] [Related]
4. 3D calculation of absorbed dose for 131I-targeted radiotherapy: a Monte Carlo study.
Saeedzadeh E; Sarkar S; Abbaspour Tehrani-Fard A; Ay MR; Khosravi HR; Loudos G
Radiat Prot Dosimetry; 2012 Jul; 150(3):298-305. PubMed ID: 22069233
[TBL] [Abstract][Full Text] [Related]
5. Methodology to incorporate biologically effective dose and equivalent uniform dose in patient-specific 3-dimensional dosimetry for non-Hodgkin lymphoma patients targeted with 131I-tositumomab therapy.
Amro H; Wilderman SJ; Dewaraja YK; Roberson PL
J Nucl Med; 2010 Apr; 51(4):654-9. PubMed ID: 20237032
[TBL] [Abstract][Full Text] [Related]
6. Lung toxicity in radioiodine therapy of thyroid carcinoma: development of a dose-rate method and dosimetric implications of the 80-mCi rule.
Sgouros G; Song H; Ladenson PW; Wahl RL
J Nucl Med; 2006 Dec; 47(12):1977-84. PubMed ID: 17138740
[TBL] [Abstract][Full Text] [Related]
7. 131I-tositumomab radioimmunotherapy: initial tumor dose-response results using 3-dimensional dosimetry including radiobiologic modeling.
Dewaraja YK; Schipper MJ; Roberson PL; Wilderman SJ; Amro H; Regan DD; Koral KF; Kaminski MS; Avram AM
J Nucl Med; 2010 Jul; 51(7):1155-62. PubMed ID: 20554734
[TBL] [Abstract][Full Text] [Related]
8. Three-dimensional personalized Monte Carlo dosimetry in 90Y resin microspheres therapy of hepatic metastases: nontumoral liver and lungs radiation protection considerations and treatment planning optimization.
Petitguillaume A; Bernardini M; Hadid L; de Labriolle-Vaylet C; Franck D; Desbrée A
J Nucl Med; 2014 Mar; 55(3):405-13. PubMed ID: 24504053
[TBL] [Abstract][Full Text] [Related]
9. Effect of image registration on 3D absorbed dose calculations in
Grassi E; Fioroni F; Berenato S; Patterson N; Ferri V; Braglia L; Filice A; Versari A; Iori M; Spezi E
Phys Med; 2018 Jan; 45():177-185. PubMed ID: 29472084
[TBL] [Abstract][Full Text] [Related]
10. A pilot study on the feasibility of real-time calculation of three-dimensional dose distribution for (153)Sm-EDTMP radionuclide therapy based on the voxel S-values.
Feng G; Lixin C; Xiaowei L; Tsao SY; Weiguang Z; Wei F
Cancer Biother Radiopharm; 2010 Jun; 25(3):345-52. PubMed ID: 20578840
[TBL] [Abstract][Full Text] [Related]
11. Patient dosimetry in nuclear medicine.
Mattsson S
Radiat Prot Dosimetry; 2015 Jul; 165(1-4):416-23. PubMed ID: 25821210
[TBL] [Abstract][Full Text] [Related]
12. Strengths and Weaknesses of a Planar Whole-Body Method of (153)Sm Dosimetry for Patients with Metastatic Osteosarcoma and Comparison with Three-Dimensional Dosimetry.
Plyku D; Loeb DM; Prideaux AR; Baechler S; Wahl RL; Sgouros G; Hobbs RF
Cancer Biother Radiopharm; 2015 Nov; 30(9):369-79. PubMed ID: 26560193
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic potential of 90Y- and 131I-labeled anti-CD20 monoclonal antibody in treating non-Hodgkin's lymphoma with pulmonary involvement: a Monte Carlo-based dosimetric analysis.
Song H; Du Y; Sgouros G; Prideaux A; Frey E; Wahl RL
J Nucl Med; 2007 Jan; 48(1):150-7. PubMed ID: 17204712
[TBL] [Abstract][Full Text] [Related]
14. Radioembolization of hepatocarcinoma with (90)Y glass microspheres: development of an individualized treatment planning strategy based on dosimetry and radiobiology.
Chiesa C; Mira M; Maccauro M; Spreafico C; Romito R; Morosi C; Camerini T; Carrara M; Pellizzari S; Negri A; Aliberti G; Sposito C; Bhoori S; Facciorusso A; Civelli E; Lanocita R; Padovano B; Migliorisi M; De Nile MC; Seregni E; Marchianò A; Crippa F; Mazzaferro V
Eur J Nucl Med Mol Imaging; 2015 Oct; 42(11):1718-1738. PubMed ID: 26112387
[TBL] [Abstract][Full Text] [Related]
15. Three-dimensional patient-specific dosimetry in radioimmunotherapy with 90Y-ibritumomab-tiuxetan.
D'Arienzo M; Cicone F; Chiacchiararelli L; Coniglio A; Delaloye AB; Scopinaro F
Cancer Biother Radiopharm; 2012 Mar; 27(2):124-33. PubMed ID: 22283680
[TBL] [Abstract][Full Text] [Related]
16. Strategies for CT tissue segmentation for Monte Carlo calculations in nuclear medicine dosimetry.
Braad PE; Andersen T; Hansen SB; Høilund-Carlsen PF
Med Phys; 2016 Dec; 43(12):6507. PubMed ID: 27908147
[TBL] [Abstract][Full Text] [Related]
17. Comparison of internal dose estimates obtained using organ-level, voxel S value, and Monte Carlo techniques.
Grimes J; Celler A
Med Phys; 2014 Sep; 41(9):092501. PubMed ID: 25186410
[TBL] [Abstract][Full Text] [Related]
18. Impact of SPECT corrections on 3D-dosimetry for liver transarterial radioembolization using the patient relative calibration methodology.
Pacilio M; Ferrari M; Chiesa C; Lorenzon L; Mira M; Botta F; Becci D; Torres LA; Coca Perez M; Vergara Gil A; Basile C; Ljungberg M; Pani R; Cremonesi M
Med Phys; 2016 Jul; 43(7):4053. PubMed ID: 27370124
[TBL] [Abstract][Full Text] [Related]
19. Whole-remnant and maximum-voxel SPECT/CT dosimetry in
Mínguez P; Flux G; Genollá J; Delgado A; Rodeño E; Sjögreen Gleisner K
Med Phys; 2016 Oct; 43(10):5279-5287. PubMed ID: 28105713
[TBL] [Abstract][Full Text] [Related]
20. Quantitative analysis of 90Y Bremsstrahlung SPECT-CT images for application to 3D patient-specific dosimetry.
Fabbri C; Sarti G; Cremonesi M; Ferrari M; Di Dia A; Agostini M; Botta F; Paganelli G
Cancer Biother Radiopharm; 2009 Feb; 24(1):145-54. PubMed ID: 19243257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]